Human brucellosis is a re-emerging and neglected zoonotic disease caused by Brucella spp., with Brucella melitensis being the principal cause worldwide. Despite the disease's prevalence, serological surveillance is not routinely practiced, even in countries where Brucella is endemic. Although eradication efforts have been successful in many developed and developing countries, brucellosis continues to pose a significant health risk to both animals and humans. Transmission to humans occurs by direct or indirect contact with infected animals or their products. Veterinary professionals, especially those conducting per-vaginal examinations without proper protective gear, and animal handlers are particularly vulnerable to infection. The pathogenesis of brucellosis is complex, involving bacterial invasion of host cells, immune evasion, and the potential for chronic infection. In humans, brucellosis often becomes chronic, but in acute cases, it presents as undulant fever with nonspecific symptoms. To reduce morbidity and mortality, early diagnosis and timely antibiotic treatment are most important. For diagnosis of Brucella spp. reliable, rapid, sensitive, specific, easy-to-perform, and automated detection systems are urgently required. Currently, there is no safe and effective vaccine available for humans. Prevention relies on controlling the disease in domestic livestock, primarily through mass vaccination, effective heat treatment of dairy products, and hygienic precautions to minimize occupational exposure. Treatment requires prolonged antibiotic therapy with a combination of drugs. To control human brucellosis, awareness programs, safe livestock practices, and timely diagnosis are essential
Read full abstract